Eurazeo share falls 6.7% over one month and drops below all its moving averages

A decline that worsens the technical setup below the three moving averages

Eurazeo is down 2.19% to €46.50 during the session, deepening a monthly decline now exceeding 6.7%. The stock is trading below its 20-day MA (€48.47, gap of -4.06%), its 50-day MA (€48.54, gap of -4.20%) and its 200-day MA (€47.06, gap of -1.19%), which reflects sustained selling pressure across multiple timeframes. The price nevertheless remains above the support level at €46.28, less than half a point above this threshold.

The RSI at 46, slightly below the neutral zone, does not yet signal pronounced oversold conditions, but momentum has been clearly downward since mid-August. Over one year, the stock has lost nearly 16.7%, despite a 10.66% rebound over three months that had briefly reversed the trend during the summer.

An active buyback program and fundamentals consolidating in H1 2026

The fundamental context offers some support points. Upon publication of H1 2026 results on August 3, 2026, the company had highlighted third-party inflows increasing to €2.3 billion (versus €2.1 billion in H1 2025) and asset management EBITDA up 20%. However, net profit attributable to the group remained negative at -€6 million, and portfolio value creation on the balance sheet remained very weak at +0.3%.

Moreover, the €200 million share buyback program, announced in June 2026, was executing at approximately 14% as of September 18, representing €27 million repurchased. This program represents a structural support element, even if it has not been sufficient to halt the monthly decline. The €46.28 support level remains the immediate technical reference to watch for the rest of the session.